Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLASH: Dose Ranging of CHF 1531 pMDI in Asthma
NCT03086460Phase 2Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Sep 2017
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of formoterol in asthma, sponsored by Chiesi Farmaceutici S.p.A.. Started Sep 2017; status: completed.
02
Drugs
formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03086460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03086460.